Overview

Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants

Status:
Completed
Trial end date:
2017-07-20
Target enrollment:
Participant gender:
Summary
An intravenous infusion in healthy subjects to obtain information about the absorption, metabolism, and excretion (AME) of BMS-986231
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb